← All trials
NCT04751916
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 5, 2021
- Primary completion
- Aug 15, 2022
- Completion date
- Oct 17, 2022
- First posted
- Feb 12, 2021
- Last posted
- Feb 12, 2021
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Oregon Health and Science UniversityLead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator
- Oregon Health and Science UniversityReponsible party - principal investigator
- Oregon Health and Science UniversityOverall official - principal investigator
- The Amino Company, LLCCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.